Evidence map›Paper›PMID 38435446›Full record

ArticleCase reports in oncology

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.

Takahiro Osuga, Shingo Tanaka, Tomohiro Kubo, Kota Hamaguchi, Ryo Ito, Akira Sakurada, Keidai Ishikawa, Koji Miyanishi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takahiro OsugaDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Shingo TanakaDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Tomohiro KuboDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Kota HamaguchiDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Ryo ItoDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Akira SakuradaGastroenterology, Otaru Ekisaikai Hospital, Hokkaido, Japan.
Keidai IshikawaThoracic surgery, Otaru Kyokai Hospital, Hokkaido, Japan.
Koji MiyanishiDepartment of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Sapporo Medical University · JPOsaka Ekisaikai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases. Case Presentation: Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8. Fourteen months thereafter, despite lack of intrahepatic recurrence, a single new 26-mm-sized mass was found in S10 of the right lung. The patient underwent right lower lobectomy. The histopathological diagnosis was HCC metastasis. Because no residual disease could be found, she was followed up without any additional treatment after surgery. She remains alive with no signs of recurrence 3 years later. Conclusion: HCC patients who relapse with lung metastases but without intrahepatic recurrence after RFA are extremely rare, especially when RFA is used to treat HCC lesions <30 mm. However, it should be noted that, although rare, HCC may recur in the form of extrahepatic metastases after RFA. Furthermore, it is suggested that, as in the presently-described case, at least some patients without intrahepatic recurrence whose lung metastases are completely resected have a good prognosis even without additional treatment for HCC.

Indexed as

Hepatocellular carcinomaPulmonary metastasisRadiofrequency ablation

Identifiers

PMID38435446
PMCPMC10907002
OpenAlexW4392364599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.